Pricing Log in Create free account

InMode Ltd. (INMD) vs PROCEPT BioRobotics Corporation (PRCT)

InMode Ltd. and PROCEPT BioRobotics Corporation are both Medical Devices companies. PROCEPT BioRobotics Corporation is the larger, with a market value of $1.0B against $824.0M — 1.3× the size. PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; InMode Ltd. trades at 11.3×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against −6.71%. InMode Ltd. has the higher net margin (20.7% vs −32.5%) and the higher return on invested capital (33.8% vs −43.6%). Across the 19 metrics below, InMode Ltd. leads on 16 and PROCEPT BioRobotics Corporation on 3.

Valuation

Metric INMD PRCT Medical Devices median
P/E 11.33 n/m 23.22
P/S 2.23 2.97 2.34
P/B 1.22 2.95 2.33
Price to free cash flow 10.11 n/m 23.72
EV/EBITDA 4.76 n/m 11.54
EV/Sales 0.89 2.46 2.24
Earnings yield 8.83% (11.04%) (10.09%)
Free cash flow yield 9.89% (8.47%) (8.47%)

Profitability

Metric INMD PRCT Medical Devices median
Gross margin 76.52% 64.22% 56.01%
Operating margin 18.47% (33.86%) (15.03%)
Net margin 20.69% (32.54%) (20.40%)
Free cash flow margin 22.03% (25.17%) (7.24%)
Return on equity 0.00% (30.24%) (15.32%)
Return on assets 10.85% (22.12%) (19.72%)
Return on invested capital 33.78% (43.57%) (10.33%)

Growth

Metric INMD PRCT Medical Devices median
Revenue growth (TTM) (6.71%) 22.69% 8.80%
EPS growth (last fiscal year) (36.44%) 1.71% 29.03%
Revenue growth, 5-year CAGR 12.44% 109.04% 15.47%
Net income growth, 5-year CAGR 4.57% 0.00% 0.00%

Health

Metric INMD PRCT Medical Devices median
Debt to equity 0.00 0.15 0.07
Current ratio 8.18 6.55 2.50
Net debt to EBITDA (6.45) 2.41 0.49

Dividend

Metric INMD PRCT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric INMD PRCT Medical Devices median
Market cap 824.03m 1.04b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack